Trial Profile
Analysis of factors for Bio-free remission due to the Tight control by Remicade in rheumatoid arthritis patients. Birdie study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms BIRDIE
- 07 Jan 2013 New trial record